Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Famciclovir or its saltsPDL I DEC / 13
Famotidine and its salts.

For human use - when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 600 mg of famotidine.

III MAY / 08
Famotidine and its salts..

For human use - when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing no more than 600 mg of famotidine.

U FEB / 07
Famotidine or its saltsPDL

For human use - except when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn.

I DEC / 13
Famotidine or its saltsPDL

For veterinary use.

I DEC / 13
Fampridine or its salts or derivativesPDL I DEC / 13
Febuxostat or its salts or derivativesPDL I DEC / 13
Felodipine or its saltsPDL I DEC / 13
Fenetylline and any salt thereofC5 I JAN / 03
Fenfluramine or its saltsPDL

Including but not limited to dexfenfluramine.

I DEC / 13
FenofibratePDL I DEC / 13
Fenoprofen or its saltsPDL I DEC / 13
Fenoterol or its saltsPDL I DEC / 13
FenproporexTS I JUN / 02
FentanylN I JUN / 02
Fesoterodine or its saltsPDL

Including but not limited to fesoterodine fumarate.

I DEC / 13
Fexofenadine hydrochloride in products marketed for adult use (12 years and older) U APR / 07
Fexofenadine hydrochloride. in products marketed for paediatric use (under 12 years of age) III APR / 07
Fibrin II SEP / 98
Fibrinolysin II SEP / 98
Fidaxomicin or its derivativesPDL I DEC / 13
FilgrastimPDL I DEC / 13
Finafloxacin or its salts or its derivativesPDL I AUG / 16
FinasteridePDL I DEC / 13
Fingolimod or its salts or derivativesPDL

Including but not limited to fingolimod hydrochloride.

I DEC / 13
FirocoxibPDL I DEC / 13
Flavoxate or its saltsPDL I DEC / 13
Flecainide or its saltsPDL I DEC / 13
Fleroxacin or its salts or derivativesPDL I DEC / 13
Flibanserin or its saltsPDL I MAY / 18
FloctafeninePDL I DEC / 13
Florfenicol or its derivativesPDL I DEC / 13
FluconazolePDL

For veterinary use.

I DEC / 13
FluconazolePDL

For human use - except when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis.

I DEC / 13
Fluconazole

For human use - when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis, in package sizes containing no more than 150 mg of fluconazole.

III MAR / 10
FlucytosinePDL I DEC / 13
Fludarabine or its salts or derivativesPDL I DEC / 13
FludiazepamTS I JUN / 02
Flumazenil I SEP / 98
Flunarizine or its saltsPDL I DEC / 13
FlunitrazepamTS I JUN / 02
Flunixin or its salts or derivativesPDL

Including but not limited to flunixin meglumine.

I DEC / 13
Fluoride or its salts (see sodium fluoride)PDL

For human use - in solid oral dosage forms containing more than 1 mg of fluoride ion.

I DEC / 13
Fluoride or its salts (see sodium fluoride).

in oral preparations containing 1 mg or less of fluoride ion per dosage unit

III SEP / 98
Fluorouracil or its derivativesPDL

Including but not limited to capecitabine, tegafur.

I DEC / 13
Fluoxetine or its saltsPDL I DEC / 13
FluoxymesteroneC3 I JUN / 02
Flupentixol or its salts or derivativesPDL

Including but not limited to flupentixol decanoate.

I DEC / 13
Fluphenazine or its saltsPDL I DEC / 13
FluralanerPDL I JUN / 14
Flurazepam and its saltsTS I SEP / 98
Flurbiprofen or its saltsPDL I DEC / 13
FluspirilenePDL I DEC / 13
FlutamidePDL I DEC / 13
Fluticasone propionate when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing no more than 120 metered sprays III AUG / 16
Fluticasone propionate when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing more than 120 metered sprays II AUG / 16
Fluvastatin or its salts or derivativesPDL I DEC / 13
Fluvoxamine or its saltsPDL I DEC / 13
Folic acidPDL

For human use - in oral dosage form containing more than 1.0 milligram of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 milligram of folic acid.

I DEC / 13
Follicle stimulating hormonePDL

including but not limited to: follitropin alpha, follitropin beta, follitropin delta

I DEC / 13
Fomepizole or its saltsPDL I DEC / 13
Fondaparinux sodiumPDL I DEC / 13
FormeboloneC3 I SEP / 98
Formestane or its derivativesPDL I DEC / 13
Formoterol or its saltsPDL I DEC / 13
Foscarnet sodiumPDL I DEC / 13
Fosfomycin or its saltsPDL I DEC / 13
Fosinopril or its saltsPDL I DEC / 13
Fosphenytoin or its saltsPDL I DEC / 13
Fractar III SEP / 98
Framycetin or its salts or derivativesPDL

For human use. 

I DEC / 13
Frovatriptan or its saltsPDL I DEC / 13
FulvestrantPDL I DEC / 13
Furaltadone or its saltsPDL

For human use.

I DEC / 13
FurazabolC3 I SEP / 98
Furazolidone or its saltsPDL

For human use.

I DEC / 13
FurethidineN I JUN / 02
FurosemidePDL

For human use.

I DEC / 13
Fusidic acid or its saltsPDL I DEC / 13

79 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled